Concerto HealthAI, Pfizer to use real-world data, AI in precision cancer deal

Concerto HealthAI and Pfizer partnered to use artificial intelligence and real-world data to help identify patients who may benefit from new therapeutic combinations of the pharma's investigational and marketed therapies for solid tumors and hematologic malignancies.

The partners will use Concerto's eurekaHealth platform and AI models along with real-world data sets from medical records, healthcare claims and American Society of Clinical Oncology’s CancerLinQ initiative to conduct synthetic control arm and prospective real-world outcomes studies...